Drug intelligence / Profile preview

NSC232003

Development stage
Preclinical
Lead developer
Inserm
Modality
Small Molecules
01

Overview

NSC232003 is a small molecule inhibitor of Ubiquitin-like with PHD and RING finger domains 1 (UHRF1), an epigenetic regulator that plays a key role in maintaining DNA methylation. NSC232003 binds to the 5-methylcytosine (5mC) binding pocket of the SRA domain of UHRF1, disrupting the interaction between UHRF1 and DNA methyltransferase 1 (DNMT1). This disruption leads to global DNA demethylation and the reactivation of tumor suppressor genes. Preclinical studies have investigated NSC232003 for its anticancer activity in various malignancies, including glioma and bladder cancer, as well as its potential to enhance immunotherapy responsiveness in autosomal dominant polycystic kidney disease (ADPKD) by remodeling the immunosuppressive microenvironment.

Other names
(5Z)-5-[1-(hydroxyamino)ethylidene]-2,3,4,5-tetrahydropyrimidine-2,4-dioneCAS 1905453-18-0CAS1905453-18-0CAS-1905453-18-0
02

Targets

UHRF1 (Ubiquitin-like with PHD and ring finger domains 1)

Beyond the preview

Go deeper on NSC232003.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NSC232003.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call